Theratechnologies Shares Surge Premarket on Deal to Go Private

Dow Jones

2025/07/03

By Colin Kellaher

Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million.

Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company.

Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million.

U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading.

The deal is slated to close by the end of November.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

July 03, 2025 06:03 ET (10:03 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2548089628"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2548089628\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2548089628?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-03 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548089628","market":"fut","top_or_hot":-1,"title":"Theratechnologies Shares Surge Premarket on Deal to Go Private","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million. \n</p>\n<p>\n  Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company. \n</p>\n<p>\n  Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million. \n</p>\n<p>\n  U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading. \n</p>\n<p>\n  The deal is slated to close by the end of November. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 03, 2025 06:03 ET (10:03 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Theratechnologies Shares Surge Premarket on Deal to Go Private</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTheratechnologies Shares Surge Premarket on Deal to Go Private\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-03 18:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million. \n</p>\n<p>\n  Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company. \n</p>\n<p>\n  Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million. \n</p>\n<p>\n  U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading. \n</p>\n<p>\n  The deal is slated to close by the end of November. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 03, 2025 06:03 ET (10:03 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"THTX","symbol_name":"Theratechnologies, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2548089628","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548089628","pubTimestamp":1751536980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million.Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company.Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million.U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading.The deal is slated to close by the end of November.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"THTX":"Theratechnologies, Inc.","BK4139":"生物科技"},"translate_title":"Theratechnologies股价因私有化交易盘前飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"THTX":0.9},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million. \n\n\n  Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company. \n\n\n  Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million. \n\n\n  U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading. \n\n\n  The deal is slated to close by the end of November. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 03, 2025 06:03 ET (10:03 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}